Navigation Links
Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
Date:8/27/2013

SAN DIEGO, Aug. 27, 2013 /PRNewswire/ -- Carolus Therapeutics, Inc. and The Alpha-1 Project, Inc. (TAP), a wholly-owned subsidiary of the Alpha-1 Foundation, today announced that they are collaborating to characterize human biological samples for the presence of the novel target, RANTES:PF4 heterodimer (the heteromer), a soluble protein complex that is secreted by activated platelets and implicated in many inflammation-related diseases, including genetic emphysema and COPD (chronic obstructive pulmonary disease). As a part of the collaboration, TAP is making an equity investment in Carolus. Terms of the collaboration and equity investment were not disclosed.

"COPD is a major and growing cause of death in the United States, and treatment approaches are generally limited to bronchodilators and anti-inflammatory agents," said John Walsh, Co-founder, President and CEO of the Alpha-1 Foundation and Co-founder and President of the COPD Foundation. "Those of us with Alpha-1 are among a small minority with a specific treatment. But clearly, all patients need more and better ways to manage these diseases. Creatively investing in potential new therapies is exactly the reason TAP was created. Carolus is approaching COPD treatment from a completely novel mechanism, which we hope will open up new ways to help patients, and we are committed to supporting their work."

Genetic emphysema is caused by a deficiency in alpha-1 antitrypsin (AAT), a protein that protects tissues such as lung from the destructive enzymes of inflammatory cells. In people who have AAT deficiencies, these inflammatory enzymes cause excessive breakdown of lung tissue, resulting in emphysema – also a key feature of a syndrome known as COPD (chronic obstructive pulmonary disease).

"I've been working on the
'/>"/>

SOURCE Carolus Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics Announces Management Changes
2. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
3. aTyr Pharma Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
4. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
5. PTC Therapeutics Reports Second Quarter 2013 Financial and Corporate Results
6. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
7. Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics
8. Northwest Biotherapeutics Announces Registered Direct Offering
9. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
10. Echo Therapeutics Announces Second Quarter 2013 Financial Results
11. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
(Date:7/11/2014)... The International Concussion Organization is hosting ... Buy Theater in Times Square, New York on ... concussion epidemic that is plaguing athletes in nearly ... , The Symposium gathers more than a dozen ... athletes and legal scholars for engaging and uniquely ...
(Date:7/11/2014)... New Mexico (PRWEB) July 11, 2014 ... stress disorder are just some of the increasing numbers ... them to lead more independent and productive lives. ... the workplace? Or is an assistance dog an impediment ... Assistance Dog Week , August 3 - 9, 2014, ...
(Date:7/11/2014)... 2014 Shu Cosmetic Surgery announces ... each qualifying patient undergoing a laser vaginal ... laser vaginal rejuvenation, an advanced type of vaginal ... procedure decreases the internal and external diameters of ... strength, and control, resulting in enhanced sexual gratification ...
(Date:7/10/2014)... The Capital Institute for Neurosciences at ... procedure in a clinical trial that delivers chemotherapy to ... , During the procedure, done at Capital Health Medical ... threaded a tiny catheter through the patient’s femoral artery ... and into the brain. Once the catheter reached the ...
(Date:7/10/2014)... 10, 2014 Thousands of researchers ... Copenhagen this July 13-17 to reveal the latest ... closer to breakthroughs in dementia science. The Alzheimer’s ... conference of its kind. , As part of ... a catalyst for generating new knowledge about dementia ...
Breaking Medicine News(10 mins):Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3
... and Philadelphia, US June 17, 2008 Shire ... company, today announced the publication of data from a ... ulcerative colitis (UC) drug Lialda™ (mesalamine). The primary endpoints ... tolerability of Lialda in mild-to-moderate UC patients over 12 ...
... the 54th Summer Fancy Food Show in New York City from June ... ... WORLDFOODS provides the perfect,product for those with food allergies, are lactose ... out on,great taste. WORLDFOODS offers an exciting variety of 59 types of ...
... Patient Advocate Foundation in Supporting,Progressive, Financially Sound and ... Support by Wearing Blue and Yellow Ribbons on,June ... the,need for all patients in Tennessee to have ... strikes, Governor Phil Bredesen, for the,second consecutive year, ...
... 17 Kimberly-Clark Professional is,donating thousands of health ... residents clean up from the extensive damage caused ... was hit very hard by these storms and ... of,Kimberly-Clark Professional, North America. "At Kimberly-Clark,Professional, our mission ...
... Provide Perfect Medium for Showing Support and, Generating Awareness - ... ... SAN MATEO, Calif., June 17 CafePress, the recognized,leader in ... launched Stand Up To Cancer initiative, to raise money for,research geared ...
... July 18-20, WASHINGTON, June 17 A ... plans and health networks wrestling with,market demands for ... services., (Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO ), ... Institute, June 18-20,in San Francisco. URAC is an ...
Cached Medicine News:Health News:Long-term safety data on Lialda published in leading GI journal 2Health News:Long-term safety data on Lialda published in leading GI journal 3Health News:WORLDFOODS Provides All Natural Authentic Asian Sauces That Cater to Vegetarians, Celiacs and Those With Food Allergies 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 3Health News:CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 3
... important missions, require dependable transport ... your destination. The VIKING Guiding ... So you can set your ... not have to think about ...
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
... RX ACCULINK Carotid Stent System is designed to ... who have carotid atherosclerosis and are at high ... wire compatible RX ACCULINK Carotid Stent System is ... stent sizes. The RX ACCULINK utilizes rapid exchange ...
Tests for protan and deutan defects. Patients must identify numbers or patterns formed in a matrix of small colored dots varying in color and intensity. Two editions available: 38 plate for detailed ...
Medicine Products: